106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2021 All rights reserved
AGACROL7213
Disclaimer
is pocket guide attempts to define principles of practice that should produce high-quality
patient care. It focuses on the needs of primary care practice, but also is applicable to providers
at all levels. is pocket guide should not be considered exclusive of other methods of care
reasonably directed at obtaining the same results. e ultimate judgment concerning the
propriety of any course of conduct must be made by the clinician aer consideration of each
individual patient situation. Neither IGC, the medical associations, nor the authors endorse
any product or service associated with the distributor of this clinical reference tool.
Source
Feuerstein JD, Ho EY, Shmidt E, Singh H, Falck-Ytter Y, Sultan S, Terdiman JP.
AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe
Luminal and Perianal Fistulizing Crohn's Disease. Gastroenterolog y 2021;160:2496–2508.
Abbreviations
AGA, American Gastroenterological Association; CD, Crohn's disease; GRADE,
Grading of Recommendations Assessment; Development and Evaluation, PML,
progressive multifocal leukoencephalopathy; TNF, tumor necrosis factor
AGA Institute Guideline on the Medical Management of
Moderate to Severe Luminal and Fistulizing Crohn's Disease
Visit gastro.org/guidelinesapp to learn about the AGA Clinical Guidelines App.
Available for download on the iTunes and Google Play Store.
